Prof. Gobardhan Das appointed to NITI Aayog; PM Modi commends his contributions to R&D
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
nSEPIA aims to bring structure to an area long dominated by subjectivity
The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security
Subscribe To Our Newsletter & Stay Updated